Literature DB >> 25349660

2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

John Freebody1, Eva A Wegner1, Monica A Rossleigh1.   

Abstract

Positron emission tomography (PET) is a minimally invasive technique which has been well validated for the diagnosis, staging, monitoring of response to therapy, and disease surveillance of adult oncology patients. Traditionally the value of PET and PET/computed tomography (CT) hybrid imaging has been less clearly defined for paediatric oncology. However recent evidence has emerged regarding the diagnostic utility of these modalities, and they are becoming increasingly important tools in the evaluation and monitoring of children with known or suspected malignant disease. Important indications for 2-deoxy-2-((18)F)fluoro-D-glucose (FDG) PET in paediatric oncology include lymphoma, brain tumours, sarcoma, neuroblastoma, Langerhans cell histiocytosis, urogenital tumours and neurofibromatosis type I. This article aims to review current evidence for the use of FDG PET and PET/CT in these indications. Attention will also be given to technical and logistical issues, the description of common imaging pitfalls, and dosimetric concerns as they relate to paediatric oncology.

Entities:  

Keywords:  Computed tomography; Dosimetry; Fluorodeoxyglucose F18; Oncology; Paediatrics; Positron emission tomography; Technical issues

Year:  2014        PMID： 25349660      PMCID： PMC4209422          DOI： 10.4329/wjr.v6.i10.741

Source DB:  PubMed          Journal:  World J Radiol        ISSN： 1949-8470


  143 in total

1.  Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.

Authors:  Joanna Begent; Neil J Sebire; Gill Levitt; Penelope Brock; Kathy Pritchard Jones; Peter Ell; Isky Gordon; John Anderson
Journal:  Eur J Cancer       Date:  2010-11-10       Impact factor: 9.162

2.  PET-CT in pediatric Langerhans cell histiocytosis.

Authors:  Sue C Kaste; Carlos Rodriguez-Galindo; Mary E McCarville; Barry L Shulkin
Journal:  Pediatr Radiol       Date:  2007-05-22

Review 3.  Pediatric genitourinary tumors.

Authors:  Kevin S Buckley
Journal:  Curr Opin Oncol       Date:  2012-05       Impact factor: 3.645

4.  Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.

Authors:  Gang Cheng; Wengen Chen; Wichana Chamroonrat; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-20       Impact factor: 9.236

5.  Positron emission tomography using [18F] fluorodeoxyglucose and [11C] l-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors.

Authors:  A M Kaplan; M A Lawson; J Spataro; D J Bandy; C T Bonstelle; S D Moss; K H Manwaring; E M Reiman
Journal:  J Child Neurol       Date:  1999-10       Impact factor: 1.987

6.  18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

Authors:  Kenneth J Biehl; Feng-Ming Kong; Farrokh Dehdashti; Jian-Yue Jin; Sasa Mutic; Issam El Naqa; Barry A Siegel; Jeffrey D Bradley
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057

7.  Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CT.

Authors:  Matthias K Werner; J Anthony Parker; Gerald M Kolodny; Jeffrey R English; Matthew R Palmer
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

8.  Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.

Authors:  Germaine R Johnson; Hongming Zhuang; Jehanzeb Khan; Stephen B Chiang; Abass Alavi
Journal:  Clin Nucl Med       Date:  2003-10       Impact factor: 7.794

Review 9.  MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma.

Authors:  A Boubaker; A Bischof Delaloye
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-12       Impact factor: 2.346

10.  The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood.

Authors:  Michael C Kruer; Allen M Kaplan; Michael M Etzl; David F Carpentieri; Paul S Dickman; Kewei Chen; Kathleen Mathieson; Alison Irving
Journal:  J Neurooncol       Date:  2009-06-09       Impact factor: 4.130
View more
  11 in total

Review 1.  18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.

Authors:  Krishan Kant Agarwal; Rachna Seth; Abhishek Behra; Manisha Jana; Rakesh Kumar
Journal:  Jpn J Radiol       Date:  2016-01-13       Impact factor: 2.374

Review 2.  Energy metabolism in neuroblastoma and Wilms tumor.

Authors:  Sepideh Aminzadeh; Silvia Vidali; Wolfgang Sperl; Barbara Kofler; René G Feichtinger
Journal:  Transl Pediatr       Date:  2015-01

3.  A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.

Authors:  Francesco Maria Calabrese; Rosanna Clima; Piero Pignataro; Vito Alessandro Lasorsa; Michael D Hogarty; Aurora Castellano; Massimo Conte; Gian Paolo Tonini; Achille Iolascon; Giuseppe Gasparre; Mario Capasso
Journal:  Oncotarget       Date:  2016-08-02

4.  Localized Chronic Form of Langerhans Cell Histiocytosis in the Femur of a 16-Year-Old Male Successfully Treated with Radiofrequency Ablation.

Authors:  Kyriakos Papavasiliou; Antonia Bintoudi; Apostolos Vlahodimos; Eleftherios Tsiridis; Prodromos Hytiroglou; Ioannis Tsitouridis; Fares Sayegh
Journal:  Case Rep Oncol Med       Date:  2020-06-16

5.  18Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies

Authors:  Nilüfer Bıçakçı; Murat Elli
Journal:  Mol Imaging Radionucl Ther       Date:  2021-02-09

6.  The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.

Authors:  Mingfei Zuo; Lan Yao; Lijuan Wen; Jianfei Shen; Na Zhang; Tian Bai; Qicheng Huang
Journal:  World J Surg Oncol       Date:  2021-09-01       Impact factor: 2.754

7.  A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

Authors:  Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Silvia Vidali; Felix Locker; Tricia Rutherford; Maura O'Donnel; Andrea Stöger-Kleiber; Johannes Adalbert Mayr; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-08-08

8.  Differential diagnostic value of 18F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging.

Authors:  Xiaojiang He; Long Zhao; Xiuyu Guo; Liang Zhao; Jing Wu; Jingxiong Huang; Long Sun; Chengrong Xie; Haojun Chen
Journal:  Cancer Manag Res       Date:  2018-07-18       Impact factor: 3.989

Review 9.  How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting.

Authors:  Gabrielle C Colleran; Neha Kwatra; Leah Oberg; Frederick D Grant; Laura Drubach; Michael J Callahan; Robert D MacDougall; Frederic H Fahey; Stephan D Voss
Journal:  Cancer Imaging       Date:  2017-11-07       Impact factor: 3.909

10.  Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT.

Authors:  Stefan A Koerber; R Finck; K Dendl; M Uhl; T Lindner; C Kratochwil; M Röhrich; H Rathke; G Ungerechts; S Adeberg; K Herfarth; D Jaeger; J Debus; U Haberkorn; F L Giesel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-21       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.